Skip to main content

Peer Review reports

From: Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas

Original Submission
24 Sep 2009 Submitted Original manuscript
3 Dec 2009 Reviewed Reviewer Report - sophie barille-nion
14 Mar 2010 Reviewed Reviewer Report - Marcus Wiedmann
Resubmission - Version 2
Submitted Manuscript version 2
29 Jun 2010 Author responded Author comments - ymera pignochino
Resubmission - Version 3
29 Jun 2010 Submitted Manuscript version 3
2 Jul 2010 Reviewed Reviewer Report - Marcus Wiedmann
16 Aug 2010 Reviewed Reviewer Report - sophie barille-nion
31 Aug 2010 Author responded Author comments - ymera pignochino
Resubmission - Version 4
31 Aug 2010 Submitted Manuscript version 4
31 Aug 2010 Author responded Author comments - ymera pignochino
Resubmission - Version 5
31 Aug 2010 Submitted Manuscript version 5
16 Nov 2010 Author responded Author comments - ymera pignochino
Resubmission - Version 6
16 Nov 2010 Submitted Manuscript version 6
Resubmission - Version 7
Submitted Manuscript version 7
17 Nov 2010 Author responded Author comments - ymera pignochino
Resubmission - Version 8
17 Nov 2010 Submitted Manuscript version 8
Publishing
18 Nov 2010 Editorially accepted
18 Nov 2010 Article published 10.1186/1471-2407-10-631

You can find further information about peer review here.

Back to article page